Olpasiran Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: AMG 890

Pipeline

Phase 3: 2

Top Sponsors

Amgen2

Indications

Heart Disease2
Cardiovascular Disease2

Alexander City, Alabama1 trial

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Advanced Cardiovascular LLC

Phase 3

Bridgeport, Connecticut1 trial

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Bridgeport Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.